In NQO1-overexpressing cancer cells, ROS production in response to β-lapachone causes DNA damage and thereby triggers PARP-mediated NAD degradation to such an extent that it outweighs the possible increase in NAD caused by NQO1, ultimately causing cancer cell demise via NAD and ATP shortage [182,183]. The gene discussed is NQO1; the disease is cancer.